Player size: small large

ISHLTv_03 - New Frontiers in Heart and Lung Transplantation: ISHLT2020 Plenary Session Selections II

Jul 14, 2020 3:00pm ‐ Jul 14, 2020 4:30pm

Members: Free

Overview
Comments

This session aired live on June 24, 2020.

Welcome and President's Message
Joseph Rogers, MD

Program Panel Introduction
Peter Hopkins, FRACP

Featured Presentation: (154) Alpha 1 Antitrypsin Treatment during Human Ex Vivo Lung Perfusion Improves Lung Function by Protecting Lung Endothelium
Andrea Mariscal, MD, PhD

Featured Discussant Q & A
Göran Dellgren, MD, PhD

Featured Presentation: (3) The Fontan VAD Physiology Project (FVPP)
Ari Michael Cedars, MD

Featured Discussant Q & A
Matthew Fenton, MB BS, BSc MRCPCH

MAID - Medical Assistance in Dying: Implications for Transplantation
James Downar, MDCM, MHSc
Palliative Care focuses on improving quality of life and symptom control for people with incurable or life-threatening disease. In some countries patients can receive medical assistance in dying (MAID). This practice raises important ethical, moral and legal issues. Organ donation after circulatory determination of death (DCD) is a widely accepted practice nowadays. Although most people who receive MAID are ineligible to donate their organs, some countries allow this to take place for donors who are eligible. The combination of DCD and MAID raises additional legal and ethical concerns, which patients and clinicians need to be aware of. This presentation will give an overview of the current guidelines and principles in Canada.

Moderated Q & A
Pamela Combs, PhD, RN

Featured Presentation: (4) Artificial Intelligence for Early Prediction of Pulmonary Hypertension Using Electrocardiography
Kyung-Hee Kim, MD, PhD

Featured Discussant Q & A
Paul Corris, MB FRCP

ISHLT Announcements
Greg Schultz, CEO

Speaker(s):

Joseph Rogers, MD, Chief Medical Officer<br>Professor of Medicine – Cardiology<br>Durham, NC, USA<p></p>, Duke University Health System
Peter M. Hopkins, FRACP, Director Queensland Lung Transplant Service, Executive Director Heart-Lung Clinical Stream, Professor Faculty of Medicine, University of Queensland, The Prince Charles Hospital, Brisbane, Australia
Andrea Mariscal, MD, PhD, Post doctoral fellow in thoracic surgery, Latner Thoracic Surgery Research Laboratories; University Health Network, Toronto General Research Institute, Toronto, ON, Canada
Göran Dellgren, MD, Professor and Consultant, Director Heart and Lung Transplantation, Mechanical Assist; Dept. Cardiothoracic Surgery and Transplant Institute, Sahlgrenska University Hospital and University of Gothenburg, Gothenburg, Sweden
Ari Cedars, MD, Director, Adult Congenital Heart Disease; Associate Professor of Medicine, Johns Hopkins University, Baltimore, MD, USA
Matthew Fenton, MB BS, BSc MRCPCH, Director, Paediatric Cardiac Transplant; Consultant Paediatric Cardiologist, Great Ormond Street Hospital, London, United Kingdom
James Downar, MDCM, MHSc, Head, Division of Palliative Care; Associate Professor, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
Pam Combs, PhD, RN, Clinical Research Nurse, Cardiac Surgery, University of Chicago, Chicago, IL, USA
Kyung-Hee Kim, MD, PhD, Director of Heart Transplantation, Sejong General Hospital, Seoul, South Korea
Paul Corris, MD, FRCP, Emeritus Professor of Thoracic Medicine, Newcastle University, Freeman Hospital University of Newcastle
Greg Schultz, CEO, Addison, TX, USA, International Society for Heart and Lung Transplantation

You must be logged in and own this session in order to post comments.